World's Best Scientists 2026 revealed!
Hiroshi Naganawa

Hiroshi Naganawa

D-Index & Metrics

Chemistry

D-Index
66
Citations
13985
World Ranking
7378
National Ranking
485

Biology and Biochemistry

D-Index
66
Citations
13902
World Ranking
8776
National Ranking
590

Overview

Hiroshi Naganawa is a researcher affiliated with Keio University in Japan specializing in medicine, with a primary focus on cardiology and cardiovascular medicine. Their work spans a range of topics centered on cardiac arrhythmias, pacing, and treatments related to atrial fibrillation and other cardiac conduction issues.

The main topics covered in Naganawa's research include:

  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Muscle activation and electromyography studies
  • Wireless Power Transfer Systems

Their publication record includes papers predominantly published in the journal EP Europace, with one paper appearing in the European Heart Journal. The frequent venues are:

  • EP Europace
  • European Heart Journal

Frequent collaborators in their work include:

  • Daisuke Yoshimoto
  • Yuichiro Sakamoto
  • Ryo Yamaguchi
  • Takahiko Suzuki
  • Yuko Uemura

Among their recent research publications are:

  • "Effectiveness and safety of automatic capture management via remote monitoring system in left bundle branch area pacing" (2023, EP Europace)
  • "Injury to the sinus nodal artery during radiofrequency ablation of atrial fibrillation and atrial tachycardia: its prevalence and treatment with percutaneous coronary intervention" (2024, EP Europace)
  • "Verification of intra- and inter-atrial conduction during Bachmann's bundle pacing using longitudinal bi-atrial strain" (2024, European Heart Journal)
  • "The efficacy of ablation at the entrance site of the epicardial circuit of atrial tachycardia" (2025, EP Europace)
  • "A novel approach for Bachmann's bundle pacing implantation with the lumenless, catheter-delivered pacing lead" (2025, EP Europace)

The research indicates a focus on electrophysiological interventions, pacing techniques, and ablation therapies designed to manage and treat complex cardiac arrhythmias. Their work addresses both the diagnostic aspects, such as conduction verification, and therapeutic advances, including remote monitoring and novel pacing lead implantation methods.

In addition to core cardiology research, Naganawa has contributed to studies in biomedical engineering and electrical and electronic engineering, indicating an interdisciplinary approach that supports innovations in cardiac device technology and treatment modalities.

Best Publications

  • Isolation of a novel tyrosine kinase inhibitor, lavendustin A, from Streptomyces griseolavendus

    Toshihiko Onoda;Hironobu Iinuma;Yumi Sasaki;Masa Hamada

  • New antitumor antibiotics aclacinomycins A and B.

    Toshikazu Oki;Yasue Matsuzawa;Akihiro Yoshimoto;Kenji Numata

  • A new antitumor antibiotic, spergualin: isolation and antitumor activity.

    Tomio Takeuchi;Hironobu Iinuma;Setsuko Kunimoto;Toru Masuda

  • Tetrahydropyranyl Derivatives of Daunomycin and Adriamycin

    Hamao Umezawa;Yoshikazu Takahashi;Mitsuhiro Kinoshita;Hiroshi Naganawa

  • Bacilysocin, a Novel Phospholipid Antibiotic Produced by Bacillus subtilis 168

    Norimasa Tamehiro;Yoshiko Okamoto-Hosoya;Susumu Okamoto;Makoto Ubukata

  • Diprotins A and B, inhibitors of dipeptidyl aminopeptidase IV, produced by bacteria.

    Hamao Umezawa;Takaaki Aoyagi;Keiji Ogawa;Hiroshi Naganawa

  • Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp.

    Masayuki Igarashi;Naoko Nakagawa;Norio Doi;Seiko Hattori

  • Chemistry of bleomycin. XIX Revised structures of bleomycin and phleomycin.

    Tomohisa Takita;Yasuhiko Muraoka;Tokuji Nakatani;Akio Fujii

  • Production, isolation and structure determination of a novel beta-glucosidase inhibitor, cyclophellitol, from Phellinus sp.

    Sonoko Atsumi;Kazuo Umezawa;Hironobu Iinuma;Hiroshi Naganawa

  • VALILACTONE, AN INHIBITOR OF ESTERASE, PRODUCED BY ACTINOMYCETES

    Mikio Kitahara;Masaaki Asano;Hiroshi Naganawa;Kenji Maeda

  • Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins.

    Masayuki Igarashi;Yoshiaki Takahashi;Tetsuo Shitara;Hikaru Nakamura

  • NEW ANTIFUNGAL ANTIBIOTICS, BENANOMICINS A AND B FROM AN ACTINOMYCETE

    Tomio Takeuchi;Takeshi Hara;Hiroshi Naganawa;Mayumi Okada

  • A new antibiotic, negamycin.

    Masa Hamada;Tomio Tadeuchi;Shinichi Kondo;Yoko Ikeda

  • Plipastatins: new inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. III. Structural elucidation of plipastatins.

    Takaaki Nishikiori;Hiroshi Naganawa;Yasuhiko Muraoka;Takaaki Aoyagi

  • Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes.

    Hamao Umezawa;Takaaki Aoyagi;Toshiyuki Tanaka;Hiroyuki Suda

  • Bisucaberin, a new siderophore, sensitizing tumor cells to macrophage-mediated cytolysis. II. Physico-chemical properties and structure determination.

    Atsushi Takahashi;Hikaru Nakamura;Toshiyuki Kameyama;Shogo Kurasawa

  • Structure of aureobasidin A.

    Katsushige Ikai;Kazutoh Takesako;Kazuro Shiomi;Makoto Moriguchi

  • The structure of nagstatin, a new inhibitor of N-acetyl-beta-D-glucosaminidase.

    T Aoyama;H Naganawa;H Suda;K Uotani

  • Chemistry of bleomycin. XVIII. carbon-13 NMR studies.

    Hiroshi Naganawa;Yasuhiko Muraoka;Tomohisa Takita;Hamao Umezawa

  • Antitumor anthracycline antibiotics, aclacinomycin a and analogues. II. Structural determination.

    Toshikazu Oki;Iwao Kitamura;Yasue Matsuzawa;Norio Shibamoto

  • Caprazamycins, Novel Lipo-nucleoside Antibiotics, from Streptomyces sp.

    Masayuki Igarashi;Yoshiaki Takahashi;Tetsuo Shitara;Hikaru Nakamura

Frequent Co-Authors

Tomio Takeuchi
Tomio Takeuchi Keio University
Masa Hamada
Masa Hamada Keio University
Hamao Umezawa
Hamao Umezawa National Institutes of Health
Yoichi Iitaka
Yoichi Iitaka University of Tokyo
Kazuo Umezawa
Kazuo Umezawa Aichi Medical University
Toshikazu Oki
Toshikazu Oki Toyama Prefectural University
Munekazu Iinuma
Munekazu Iinuma Gifu Pharmaceutical University
Toshiyuki Tanaka
Toshiyuki Tanaka Hyogo University of Health Sciences
Kazuro Shiomi
Kazuro Shiomi Kitasato University
Toshiyuki Tanaka
Toshiyuki Tanaka Kyoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career paths beyond traditional laboratory roles. For those interested in the healthcare industry, becoming a pharmacist is a popular choice. To learn more about the educational timeline and requirements, exploring how long does it take to become a pharmacist provides valuable insights into this rewarding profession.

Alternatively, graduates with a chemistry background can venture into pharmaceutical sales. Understanding the drug rep salary and career paths helps gauge the opportunities and earning potential in this dynamic field.

For those interested in forensic applications of chemistry, online forensic science courses offer accessible education options. These programs provide the foundational knowledge needed to work in forensic labs or related roles, as highlighted in online forensic science courses.

Additionally, careers like an autopsy technician blend chemistry with medical investigation. Exploring the autopsy tech salary and job outlook can help students decide if this specialized pathway suits their interests and goals.

Best Scientists Citing Hiroshi Naganawa

Trending Scientists

Recently Published Articles